The verified answer
As of Aug 2026, DEPLOY verifies Revolve Surgical: 1 model, 1 active incident. 1 source back the record.
CategorySurgical robots
Overview
Canadian surgical robotics startup developing a table-mounted, zero-footprint surgical platform for minimally invasive procedures. Founded in 2019, the company received FDA 510(k) clearance in 2025 for its surgical robot system, which features reusable table-mounted arms with 5mm wristed instruments. A Y Combinator S21 alum, Revolve Surgical aims to make robotic surgery accessible to every operating room with a compact, low-cost design.
Verified record
- Verified deployments
- None on file
- Active incidents
- 1 incident on file
Key facts
FDA 510(k)
Co-founders
FDA clearance
YC batch
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Revolve Surgical on the deployment map
View the global mapRevolve Surgical has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Revolve Surgical on the DEPLOY record yet. Track Revolve Surgical to know the moment the first one is verified.
Current leadership (3)
- Peter Francis Co-Founder & CEOreported, not verified
- Alex Gordon Co-Founderreported, not verified
- Matthew Kang Co-Founder, CEO & Co-founderreported, not verified
Founders (3)
- Peter Franciscofounder
- Alex Gordoncofounder
- Matthew Kangcofounder
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Revolve Surgical (1)
- Revolve Surgical receives FDA 510(k) clearance for surgical robot platform2026-06-15 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Revolve Surgical in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- early
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 2, 2026
Added to the verified registry
- Incident recordedJun 15, 2026
Revolve Surgical receives FDA 510(k) clearance for surgical robot platform
- Deployment verifiedVerifiedNov 1, 2025
Revolve Surgical Platform at St. Michael's Hospital (Unity Health Toronto)
Sources (1)
Common questions
What is Revolve Surgical?
What does Revolve Surgical make?
Is Revolve Surgical publicly traded?
Who competes with Revolve Surgical?
Who is the CEO of Revolve Surgical?
How can I invest in Revolve Surgical?
Where is Revolve Surgical headquartered?
Who owns Revolve Surgical?
Where does Revolve Surgical operate robots?
Is Revolve Surgical a top robotics company?
Are there any incidents involving Revolve Surgical?
Is Revolve Surgical safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Revolve Surgical.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning Revolve Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
Revolve Surgical wins FDA clearance for surgical robot
Revolve Surgical received FDA 510(k) clearance for its surgical robot platform, designed as a table-mounted robot targeting ambulatory surgery centers. The Canada-based company is…
Revolve Surgical wins FDA clearance for surgical robot
Revolve Surgical received FDA 510(k) clearance for its table-mounted, zero-footprint laparoscopic surgical robot platform for general surgery, with plans for pilot studies ahead…
Revolve receives FDA clearance for surgical robot
Revolve Surgical received FDA 510(k) clearance for its table-mounted surgical robot with 5mm wristed instruments.
Revolve Surgical: Surgical robotics for every operating room
Y Combinator profile for Revolve Surgical, founded in 2019 by Peter Francis, Alex Gordon, and Matthew Kang.
Machine-readable surfaces
- Markdown mirror: /companies/revolve-surgical.md
- RSS feed: /companies/revolve-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/085e5b40-c212-4c66-94f3-7e958513db2b
- Revision history: /companies/revolve-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
Reality vs attention
Revolve Surgical draws attention at the 5th percentile but verifies reality at the 34th percentile among surgical robots. Hype Gap -28.8, 30th widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026